l 692429 has been researched along with eprosartan in 1 studies
Studies (l 692429) | Trials (l 692429) | Recent Studies (post-2010) (l 692429) | Studies (eprosartan) | Trials (eprosartan) | Recent Studies (post-2010) (eprosartan) |
---|---|---|---|---|---|
40 | 5 | 1 | 297 | 83 | 49 |
Protein | Taxonomy | l 692429 (IC50) | eprosartan (IC50) |
---|---|---|---|
ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | 6.65 | |
Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.1244 | |
Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.1244 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.1217 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schieffer, B; Schmidt, B | 1 |
1 review(s) available for l 692429 and eprosartan
Article | Year |
---|---|
Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Growth Hormone; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Models, Molecular; Receptor, Angiotensin, Type 1; Tetrazoles; Thiophenes; Thromboxane A2 | 2003 |